Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000898432-25-000189·Amneal Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
Amneal Pharmaceuticals Inc
Class A Common Stock, par value $0.01 · CUSIP: 03168L105
Event date: 2025-03-14
- Filing-level shares
- 48,578,209
- Percent of class
- 15.7%
- Patel Tushar BhikhubhaiReported CIK 0001745375
Shares: 48,578,209 · Class: 15.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000898432-25-000189
- Form type
- SCHEDULE 13D/A
- Filer
- Amneal Pharmaceuticals, Inc.
- CIK
- CIK 1723128
- Filed
- Mar 17, 2025
- Reporting period
- Mar 14, 2025
- Description
- Schedule 13D beneficial ownership